The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Metastatic Colorectal Cancer Surgery Market Research Report 2025
Synopsis
Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.
The global Metastatic Colorectal Cancer Surgery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Treatment of metastatic colorectal cancer is multidisciplinary field involving early evaluation for resection of hepatic metastasis, metastasectomy and coordinated chemotherapy or radiation therapy. Primary factors driving growth of metastatic colorectal cancer treatment market are increasing prevalence of colorectal cancer across the globe, rapid innovation in personalized medicine and discovery of new targets for treatment of colorectal cancers.
This report aims to provide a comprehensive presentation of the global market for Metastatic Colorectal Cancer Surgery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metastatic Colorectal Cancer Surgery.
Report Scope
The Metastatic Colorectal Cancer Surgery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metastatic Colorectal Cancer Surgery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metastatic Colorectal Cancer Surgery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals
Segment by Type
Tumor Resection
Portal Vein Embolization
Segment by Application
Hospitals
Clinics
Cancer Research Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metastatic Colorectal Cancer Surgery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.
The global Metastatic Colorectal Cancer Surgery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Treatment of metastatic colorectal cancer is multidisciplinary field involving early evaluation for resection of hepatic metastasis, metastasectomy and coordinated chemotherapy or radiation therapy. Primary factors driving growth of metastatic colorectal cancer treatment market are increasing prevalence of colorectal cancer across the globe, rapid innovation in personalized medicine and discovery of new targets for treatment of colorectal cancers.
This report aims to provide a comprehensive presentation of the global market for Metastatic Colorectal Cancer Surgery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metastatic Colorectal Cancer Surgery.
Report Scope
The Metastatic Colorectal Cancer Surgery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metastatic Colorectal Cancer Surgery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metastatic Colorectal Cancer Surgery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals
Segment by Type
Tumor Resection
Portal Vein Embolization
Segment by Application
Hospitals
Clinics
Cancer Research Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metastatic Colorectal Cancer Surgery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tumor Resection
1.2.3 Portal Vein Embolization
1.3 Market by Application
1.3.1 Global Metastatic Colorectal Cancer Surgery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Metastatic Colorectal Cancer Surgery Market Perspective (2019-2030)
2.2 Metastatic Colorectal Cancer Surgery Growth Trends by Region
2.2.1 Global Metastatic Colorectal Cancer Surgery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Metastatic Colorectal Cancer Surgery Historic Market Size by Region (2019-2024)
2.2.3 Metastatic Colorectal Cancer Surgery Forecasted Market Size by Region (2025-2030)
2.3 Metastatic Colorectal Cancer Surgery Market Dynamics
2.3.1 Metastatic Colorectal Cancer Surgery Industry Trends
2.3.2 Metastatic Colorectal Cancer Surgery Market Drivers
2.3.3 Metastatic Colorectal Cancer Surgery Market Challenges
2.3.4 Metastatic Colorectal Cancer Surgery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Colorectal Cancer Surgery Players by Revenue
3.1.1 Global Top Metastatic Colorectal Cancer Surgery Players by Revenue (2019-2024)
3.1.2 Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Players (2019-2024)
3.2 Global Metastatic Colorectal Cancer Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metastatic Colorectal Cancer Surgery Revenue
3.4 Global Metastatic Colorectal Cancer Surgery Market Concentration Ratio
3.4.1 Global Metastatic Colorectal Cancer Surgery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Colorectal Cancer Surgery Revenue in 2023
3.5 Metastatic Colorectal Cancer Surgery Key Players Head office and Area Served
3.6 Key Players Metastatic Colorectal Cancer Surgery Product Solution and Service
3.7 Date of Enter into Metastatic Colorectal Cancer Surgery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metastatic Colorectal Cancer Surgery Breakdown Data by Type
4.1 Global Metastatic Colorectal Cancer Surgery Historic Market Size by Type (2019-2024)
4.2 Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Type (2025-2030)
5 Metastatic Colorectal Cancer Surgery Breakdown Data by Application
5.1 Global Metastatic Colorectal Cancer Surgery Historic Market Size by Application (2019-2024)
5.2 Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Metastatic Colorectal Cancer Surgery Market Size (2019-2030)
6.2 North America Metastatic Colorectal Cancer Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Metastatic Colorectal Cancer Surgery Market Size by Country (2019-2024)
6.4 North America Metastatic Colorectal Cancer Surgery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Metastatic Colorectal Cancer Surgery Market Size (2019-2030)
7.2 Europe Metastatic Colorectal Cancer Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Metastatic Colorectal Cancer Surgery Market Size by Country (2019-2024)
7.4 Europe Metastatic Colorectal Cancer Surgery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size (2019-2030)
8.2 Asia-Pacific Metastatic Colorectal Cancer Surgery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size by Region (2019-2024)
8.4 Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Metastatic Colorectal Cancer Surgery Market Size (2019-2030)
9.2 Latin America Metastatic Colorectal Cancer Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Metastatic Colorectal Cancer Surgery Market Size by Country (2019-2024)
9.4 Latin America Metastatic Colorectal Cancer Surgery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size (2019-2030)
10.2 Middle East & Africa Metastatic Colorectal Cancer Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size by Country (2019-2024)
10.4 Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Metastatic Colorectal Cancer Surgery Introduction
11.1.4 Sanofi Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Metastatic Colorectal Cancer Surgery Introduction
11.2.4 Roche Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Metastatic Colorectal Cancer Surgery Introduction
11.3.4 Eli Lilly Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024)
11.3.5 Eli Lilly Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Metastatic Colorectal Cancer Surgery Introduction
11.4.4 Pfizer Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Metastatic Colorectal Cancer Surgery Introduction
11.5.4 Novartis Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Metastatic Colorectal Cancer Surgery Introduction
11.6.4 Amgen Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024)
11.6.5 Amgen Recent Development
11.7 Taiho Oncology
11.7.1 Taiho Oncology Company Detail
11.7.2 Taiho Oncology Business Overview
11.7.3 Taiho Oncology Metastatic Colorectal Cancer Surgery Introduction
11.7.4 Taiho Oncology Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024)
11.7.5 Taiho Oncology Recent Development
11.8 Genentech
11.8.1 Genentech Company Detail
11.8.2 Genentech Business Overview
11.8.3 Genentech Metastatic Colorectal Cancer Surgery Introduction
11.8.4 Genentech Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024)
11.8.5 Genentech Recent Development
11.9 EMD Serono
11.9.1 EMD Serono Company Detail
11.9.2 EMD Serono Business Overview
11.9.3 EMD Serono Metastatic Colorectal Cancer Surgery Introduction
11.9.4 EMD Serono Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024)
11.9.5 EMD Serono Recent Development
11.10 Suzhou Zelgen Biopharmaceuticals
11.10.1 Suzhou Zelgen Biopharmaceuticals Company Detail
11.10.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Introduction
11.10.4 Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024)
11.10.5 Suzhou Zelgen Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tumor Resection
Table 3. Key Players of Portal Vein Embolization
Table 4. Global Metastatic Colorectal Cancer Surgery Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Metastatic Colorectal Cancer Surgery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Metastatic Colorectal Cancer Surgery Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Metastatic Colorectal Cancer Surgery Market Share by Region (2019-2024)
Table 8. Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Metastatic Colorectal Cancer Surgery Market Share by Region (2025-2030)
Table 10. Metastatic Colorectal Cancer Surgery Market Trends
Table 11. Metastatic Colorectal Cancer Surgery Market Drivers
Table 12. Metastatic Colorectal Cancer Surgery Market Challenges
Table 13. Metastatic Colorectal Cancer Surgery Market Restraints
Table 14. Global Metastatic Colorectal Cancer Surgery Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Metastatic Colorectal Cancer Surgery Market Share by Players (2019-2024)
Table 16. Global Top Metastatic Colorectal Cancer Surgery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Surgery as of 2023)
Table 17. Ranking of Global Top Metastatic Colorectal Cancer Surgery Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Metastatic Colorectal Cancer Surgery Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Metastatic Colorectal Cancer Surgery Product Solution and Service
Table 21. Date of Enter into Metastatic Colorectal Cancer Surgery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Metastatic Colorectal Cancer Surgery Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Type (2019-2024)
Table 25. Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Type (2025-2030)
Table 27. Global Metastatic Colorectal Cancer Surgery Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Application (2019-2024)
Table 29. Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Metastatic Colorectal Cancer Surgery Revenue Market Share by Application (2025-2030)
Table 31. North America Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Metastatic Colorectal Cancer Surgery Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Metastatic Colorectal Cancer Surgery Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Metastatic Colorectal Cancer Surgery Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Metastatic Colorectal Cancer Surgery Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Metastatic Colorectal Cancer Surgery Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Metastatic Colorectal Cancer Surgery Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size by Country (2025-2030) & (US$ Million)
Table 46. Sanofi Company Detail
Table 47. Sanofi Business Overview
Table 48. Sanofi Metastatic Colorectal Cancer Surgery Product
Table 49. Sanofi Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024) & (US$ Million)
Table 50. Sanofi Recent Development
Table 51. Roche Company Detail
Table 52. Roche Business Overview
Table 53. Roche Metastatic Colorectal Cancer Surgery Product
Table 54. Roche Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Eli Lilly Company Detail
Table 57. Eli Lilly Business Overview
Table 58. Eli Lilly Metastatic Colorectal Cancer Surgery Product
Table 59. Eli Lilly Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024) & (US$ Million)
Table 60. Eli Lilly Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer Metastatic Colorectal Cancer Surgery Product
Table 64. Pfizer Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Novartis Company Detail
Table 67. Novartis Business Overview
Table 68. Novartis Metastatic Colorectal Cancer Surgery Product
Table 69. Novartis Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Amgen Company Detail
Table 72. Amgen Business Overview
Table 73. Amgen Metastatic Colorectal Cancer Surgery Product
Table 74. Amgen Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Taiho Oncology Company Detail
Table 77. Taiho Oncology Business Overview
Table 78. Taiho Oncology Metastatic Colorectal Cancer Surgery Product
Table 79. Taiho Oncology Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024) & (US$ Million)
Table 80. Taiho Oncology Recent Development
Table 81. Genentech Company Detail
Table 82. Genentech Business Overview
Table 83. Genentech Metastatic Colorectal Cancer Surgery Product
Table 84. Genentech Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024) & (US$ Million)
Table 85. Genentech Recent Development
Table 86. EMD Serono Company Detail
Table 87. EMD Serono Business Overview
Table 88. EMD Serono Metastatic Colorectal Cancer Surgery Product
Table 89. EMD Serono Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024) & (US$ Million)
Table 90. EMD Serono Recent Development
Table 91. Suzhou Zelgen Biopharmaceuticals Company Detail
Table 92. Suzhou Zelgen Biopharmaceuticals Business Overview
Table 93. Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Product
Table 94. Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Surgery Business (2019-2024) & (US$ Million)
Table 95. Suzhou Zelgen Biopharmaceuticals Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Colorectal Cancer Surgery Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Metastatic Colorectal Cancer Surgery Market Share by Type: 2023 VS 2030
Figure 3. Tumor Resection Features
Figure 4. Portal Vein Embolization Features
Figure 5. Global Metastatic Colorectal Cancer Surgery Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Metastatic Colorectal Cancer Surgery Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Cancer Research Centers Case Studies
Figure 10. Metastatic Colorectal Cancer Surgery Report Years Considered
Figure 11. Global Metastatic Colorectal Cancer Surgery Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Metastatic Colorectal Cancer Surgery Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Metastatic Colorectal Cancer Surgery Market Share by Region: 2023 VS 2030
Figure 14. Global Metastatic Colorectal Cancer Surgery Market Share by Players in 2023
Figure 15. Global Top Metastatic Colorectal Cancer Surgery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Surgery as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Metastatic Colorectal Cancer Surgery Revenue in 2023
Figure 17. North America Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Metastatic Colorectal Cancer Surgery Market Share by Country (2019-2030)
Figure 19. United States Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Metastatic Colorectal Cancer Surgery Market Share by Country (2019-2030)
Figure 23. Germany Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Metastatic Colorectal Cancer Surgery Market Share by Region (2019-2030)
Figure 31. China Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Metastatic Colorectal Cancer Surgery Market Share by Country (2019-2030)
Figure 39. Mexico Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Metastatic Colorectal Cancer Surgery Market Share by Country (2019-2030)
Figure 43. Turkey Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Metastatic Colorectal Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Sanofi Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2019-2024)
Figure 46. Roche Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2019-2024)
Figure 47. Eli Lilly Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2019-2024)
Figure 50. Amgen Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2019-2024)
Figure 51. Taiho Oncology Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2019-2024)
Figure 52. Genentech Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2019-2024)
Figure 53. EMD Serono Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2019-2024)
Figure 54. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Metastatic Colorectal Cancer Surgery Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
